ASX [ASE Technology] 6-K: (Original Filing)
[]
BABA [Alibaba] 13F-HR: (Original Filing)
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;} .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;} .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, s]
HPJ [Highpower International] SC 13E3: (Original Filing)
[Presentation to the Special Committee at Highpower International June 26, 2019 | June 26, 2019 CONFIDENTIAL 3 | June 26, 2019 CONFIDENTIAL Table of Contents I. Transaction Overview II. Valuation Analysis III. Appendix 4 | June 26, 2019 CONFIDENTIAL I. Transaction Overview 4 5 | June 26, 2019 CONFIDE]
CJJD [CHINA JO-JO DRUGSTORES] 10-Q: (Original Filing)
[] [CERTIFICATION I, Lei Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in ]
BABA [Alibaba] 13F-HR: .FormData {color: blue; background-color: white; font-size: small; font-family:
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;} .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;} .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, s]
HPJ [Highpower International] SC 13E3: Presentation to the Special Committee at Highpower International
[Presentation to the Special Committee at Highpower International June 26, 2019 | June 26, 2019 CONFIDENTIAL 3 | June 26, 2019 CONFIDENTIAL Table of Contents I. Transaction Overview II. Valuation Analysis III. Appendix 4 | June 26, 2019 CONFIDENTIAL I. Transaction Overview 4 5 | June 26, 2019 CONFIDE]
CJJD [CHINA JO-JO DRUGSTORES] 10-Q:
[] [CERTIFICATION I, Lei Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in ]
CO [Global Cord Blood] 20-F/A: (Original Filing)
[FORM 20-F/A Amendment No. 1 o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: Global Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albe]
HPJ [Highpower International] PREM14A: (Original Filing)
[PRELIMINARY PROXY STATEMENT - SUBJECT TO COMPLETION - DATED AUGUST 14, 2019 [ ], 2019 To the Stockholders of Highpower International, Inc.:]
